Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
fig.2.j
Dichmann DS and Harland RM (2012) |
Xla Wt + fus MO
NF11.5 (in situ hybridization) |
|
||||||
fig.3.e,m
Dichmann DS and Harland RM (2012) |
Xla Wt + fus MO
NF11.5 (in situ hybridization) |
|
||||||
fig.3.c
Dichmann DS and Harland RM (2012) |
Xla Wt + inhba
NF11.5 (in situ hybridization) |
|
||||||
fig.1.d
Ninomiya H et al. (2012) |
Xla Wt + cdh3 MO
NF12.5 (in situ hybridization) |
|
||||||
fig.6.c
Bentaya S et al. (2012) |
Xla Wt + rbm38 MO
NF14 (in situ hybridization) |
|
||||||
fig.4.i
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF13 (in situ hybridization) |
|
||||||
fig.5.a
Neuner R et al. (2009) |
Xla Wt + adam19 MO
NF12 (in situ hybridization) |
|
||||||
fig.5.c
Mir A et al. (2007) |
Xla Wt + Activin + animal cap explant
NF11 (RT-PCR) |
|
||||||
Fig. S1A c2r1, c2r2
Zamparini AL et al. (2006) |
Xla Wt + hhex MO
NF10.5 (in situ hybridization) |
|
||||||
fig.1.j
Cao Y et al. (2006) |
Xla Wt + Mmu.Pou5f1
NF11.5 (in situ hybridization) |
|